1. Home
  2. SNY vs DE Comparison

SNY vs DE Comparison

Compare SNY & DE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • DE
  • Stock Information
  • Founded
  • SNY 1994
  • DE 1837
  • Country
  • SNY France
  • DE United States
  • Employees
  • SNY N/A
  • DE N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • DE Industrial Machinery/Components
  • Sector
  • SNY Health Care
  • DE Industrials
  • Exchange
  • SNY Nasdaq
  • DE Nasdaq
  • Market Cap
  • SNY 120.2B
  • DE 110.7B
  • IPO Year
  • SNY N/A
  • DE N/A
  • Fundamental
  • Price
  • SNY $47.71
  • DE $431.49
  • Analyst Decision
  • SNY Buy
  • DE Buy
  • Analyst Count
  • SNY 2
  • DE 19
  • Target Price
  • SNY $57.50
  • DE $444.78
  • AVG Volume (30 Days)
  • SNY 2.7M
  • DE 1.4M
  • Earning Date
  • SNY 01-30-2025
  • DE 02-13-2025
  • Dividend Yield
  • SNY 4.27%
  • DE 1.50%
  • EPS Growth
  • SNY N/A
  • DE N/A
  • EPS
  • SNY 4.00
  • DE 25.62
  • Revenue
  • SNY $54,031,898,261.00
  • DE $51,532,000,000.00
  • Revenue This Year
  • SNY $3.18
  • DE N/A
  • Revenue Next Year
  • SNY $6.67
  • DE $6.01
  • P/E Ratio
  • SNY $23.72
  • DE $16.88
  • Revenue Growth
  • SNY 6.01
  • DE N/A
  • 52 Week Low
  • SNY $45.22
  • DE $340.20
  • 52 Week High
  • SNY $58.97
  • DE $469.39
  • Technical
  • Relative Strength Index (RSI)
  • SNY 45.07
  • DE 44.32
  • Support Level
  • SNY $47.01
  • DE $441.00
  • Resistance Level
  • SNY $49.73
  • DE $445.31
  • Average True Range (ATR)
  • SNY 0.73
  • DE 8.39
  • MACD
  • SNY 0.16
  • DE -4.24
  • Stochastic Oscillator
  • SNY 48.60
  • DE 10.08

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About DE Deere & Company

Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry in their green and yellow livery. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 2,000 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.

Share on Social Networks: